MSLN and neoplasm: The current study along with several preclinical and clinical studies demonstrate the significance of MSLN expression in both the host and tumor cells, making MSLN a promising target for OvCa treatment as current therapeutic effects seem moderate at best indicating further investigation is needed [12,54].